ProfileGDS5678 / 1452734_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 98% 98% 98% 99% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 110.431998
GSM967853U87-EV human glioblastoma xenograft - Control 210.651498
GSM967854U87-EV human glioblastoma xenograft - Control 310.473698
GSM967855U87-EV human glioblastoma xenograft - Control 411.342899
GSM967856U87-EV human glioblastoma xenograft - Control 510.619198
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 110.268998
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 210.423898
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 310.517698
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 410.529598
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 110.258798
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 210.253198
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 310.618498
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 410.39598
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 510.214798